Login to Your Account



FDA Pitches Soft Ball with Gattex Briefing Docs in SBS

By Catherine Shaffer
Staff Writer

Monday, October 15, 2012
Briefing documents that were released ahead of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting for short bowel drug Gattex (teduglutide) held "no surprises" according the drugmaker, NPS Pharmaceuticals Inc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription